Related Experiment Video
Updated: Jul 9, 2026
08:25
Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
Published on: April 11, 2018
14.7K
Independent Review Organization and Proton Therapy: Multistate Analysis and Legal Procedural Strategies.
Eric D Brooks1, Terence T Sio2, Matthew S Ning3
1Premier Radiation Oncology Associates, Clearwater, Florida, USA.
International Journal of Particle Therapy
|March 14, 2025
Summary
Independent Review Organizations (IROs) can help patients get insurance approval for proton therapy after initial denials. These reviews offer an objective pathway, with nearly half of denied patients eventually receiving approval.
Area of Science:
- Oncology
- Health Services Research
- Medical Policy
Background:
- Securing insurance authorization for proton therapy presents significant challenges for many medical centers.
- Independent Review Organizations (IROs) offer an independent review process for proton therapy cases denied by health insurance or employer plans.
- However, the utilization of IROs for securing approvals post-denial is often suboptimal.
Purpose of the Study:
- To analyze trends in Independent Review Organization (IRO) approvals for proton therapy.
- To identify strategies and legal procedures associated with successful IRO reviews.
- To evaluate the effectiveness of IROs in improving patient access to proton therapy.
Main Methods:
- Analysis of publicly available data on IRO approvals from California, Washington, and New York.
- Examination of trends in IRO approval rates over time.
- Qualitative assessment of factors associated with higher IRO approval rates.
Main Results:
- The aggregate IRO approval rate for proton therapy across three states was 42.1%, with increasing trends observed over time.
- Sarcoma (84.6%), GYN cancers (55.6%), and breast cancer (51.4%) had the highest approval rates.
- Referencing guidelines, citing studies, and personalized letters were linked to improved IRO approval rates, while prostate cancer had the lowest rate (16.5%).
Conclusions:
- Independent Review Organization (IRO) reviews offer a more objective remedy for patients denied proton therapy, especially those with unfavorable insurance policies.
- IRO appeals represent a valuable pathway to proton therapy access, with improving overturn rates in recent years.
- Proton therapy centers should strategically leverage IRO reviews to enhance patient access and increase approval success rates.
Related Concept Videos
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:19Quality Assurance
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
01:10Qualitative Analysis
Qualitative analysis is the process of identifying elements, ions, or compounds in an unknown sample. It is the first and most fundamental type of analysis based on the hierarchy of analytical goals. This hierarchy is significant as it provides a structured approach to scientific research, with qualitative analysis serving as the initial step, providing essential information before moving on to quantitative or other forms of analysis.
There are two main approaches to qualitative analysis:...
There are two main approaches to qualitative analysis:...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...